Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-07-21 Sale |
2021-07-23 4:54 pm |
ALEXION PHARMACEUTICALS INC. | ALXN | COUGHLIN CHRISTOPHER J Director |
42,347 | $0 | $0 | 0 (Direct) |
View |
| 2021-07-21 Sale |
2021-07-23 4:52 pm |
ALEXION PHARMACEUTICALS INC. | ALXN | SARIN ARADHANA EVP, CFO |
120,253 | $0 | $0 | 0 (Direct) |
View |
| 2021-07-21 Sale |
2021-07-23 4:51 pm |
ALEXION PHARMACEUTICALS INC. | ALXN | FRIEDMAN PAUL A Director |
12,840 | $0 | $0 | 0 (Direct) |
View |
| 2021-07-21 Sale |
2021-07-23 4:49 pm |
ALEXION PHARMACEUTICALS INC. | ALXN | Reinsdorf Judith A Director |
14,150 | $0 | $0 | 0 (Direct) |
View |
| 2021-07-21 Sale |
2021-07-23 4:48 pm |
ALEXION PHARMACEUTICALS INC. | ALXN | Dunsire Deborah Director |
14,629 | $0 | $0 | 0 (Direct) |
View |
| 2021-07-21 Sale |
2021-07-23 4:47 pm |
ALEXION PHARMACEUTICALS INC. | ALXN | Carino Tanisha EVP & CCAO |
59,226 | $0 | $0 | 0 (Direct) |
View |
| 2021-07-21 Sale |
2021-07-23 4:45 pm |
ALEXION PHARMACEUTICALS INC. | ALXN | Mollen John T Director |
15,336 | $0 | $0 | 0 (Direct) |
View |
| 2021-07-21 Sale |
2021-07-23 4:44 pm |
ALEXION PHARMACEUTICALS INC. | ALXN | Brennan David R Director |
20,873 | $0 | $0 | 0 (Direct) |
View |
| 2021-07-21 Sale |
2021-07-23 4:42 pm |
ALEXION PHARMACEUTICALS INC. | ALXN | Goff Brian EVP & Chief Commercial Officer |
150,832 | $0 | $0 | 0 (Direct) |
View |
| 2021-07-21 Sale |
2021-07-23 4:40 pm |
ALEXION PHARMACEUTICALS INC. | ALXN | Chiniara Ellen EVP & Chief Legal Officer |
116,850 | $0 | $0 | 0 (Direct) |
View |
| 2021-07-21 Sale |
2021-07-23 4:39 pm |
ALEXION PHARMACEUTICALS INC. | ALXN | Bazarko Daniel SVP, Controller, CAO |
60,207 | $0 | $0 | 0 (Direct) |
View |
| 2021-07-21 Sale |
2021-07-23 4:37 pm |
ALEXION PHARMACEUTICALS INC. | ALXN | Franchini Indrani Lall EVP, Chief Compliance Officer |
116,075 | $0 | $0 | 0 (Direct) |
View |
| 2021-07-21 Sale |
2021-07-23 4:36 pm |
ALEXION PHARMACEUTICALS INC. | ALXN | Nader Francois Director |
13,921 | $0 | $0 | 0 (Direct) |
View |
| 2021-07-21 Sale |
2021-07-23 4:34 pm |
ALEXION PHARMACEUTICALS INC. | ALXN | Rummelt Andreas Director |
28,109 | $0 | $0 | 0 (Direct) |
View |
| 2021-07-21 Sale |
2021-07-23 4:32 pm |
ALEXION PHARMACEUTICALS INC. | ALXN | HANTSON LUDWIG CEO |
580,809 | $0 | $0 | 9,098 (Direct) |
View |
| 2021-07-21 Sale |
2021-07-23 4:29 pm |
ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development |
146,511 | $0 | $0 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-07-14 Option Award |
2021-07-16 4:56 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | HANTSON LUDWIG CEO |
240,741 | $0 | 589,907 (Direct) |
View |
| 2021-07-14 Option Award |
2021-07-16 4:54 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | SARIN ARADHANA EVP, CFO |
56,313 | $0 | 120,253 (Direct) |
View |
| 2021-07-14 Option Award |
2021-07-16 4:53 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Franchini Indrani Lall EVP, Chief Compliance Officer |
52,625 | $0 | 116,075 (Direct) |
View |
| 2021-07-14 Option Award |
2021-07-16 4:49 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Bazarko Daniel SVP, Controller, CAO |
21,708 | $0 | 60,207 (Direct) |
View |
| 2021-07-14 Option Award |
2021-07-16 4:48 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development |
60,144 | $0 | 146,511 (Direct) |
View |
| 2021-07-14 Option Award |
2021-07-16 4:46 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Chiniara Ellen EVP & Chief Legal Officer |
54,469 | $0 | 116,850 (Direct) |
View |
| 2021-07-14 Option Award |
2021-07-16 4:45 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Carino Tanisha EVP & CCAO |
25,813 | $0 | 59,226 (Direct) |
View |
| 2021-07-14 Option Award |
2021-07-16 4:43 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Goff Brian EVP & Chief Commercial Officer |
60,144 | $0 | 150,832 (Direct) |
View |
| 2021-06-08 Tax Withholding |
2021-06-09 4:53 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development |
1,957 | $177 | 86,367 (Direct) |
View |
| 2021-06-08 Tax Withholding |
2021-06-09 4:52 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Goff Brian EVP & Chief Commercial Officer |
1,086 | $177 | 90,688 (Direct) |
View |
| 2021-06-08 Tax Withholding |
2021-06-09 4:50 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Franchini Indrani Lall EVP, Chief Compliance Officer |
928 | $177 | 63,450 (Direct) |
View |
| 2021-05-20 Option Award |
2021-05-24 4:36 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | COUGHLIN CHRISTOPHER J Director |
2,691 | $0 | 42,347 (Direct) |
View |
| 2021-05-20 Option Award |
2021-05-24 4:34 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | FRIEDMAN PAUL A Director |
2,495 | $0 | 12,840 (Direct) |
View |
| 2021-05-20 Option Award |
2021-05-24 4:33 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Rummelt Andreas Director |
2,495 | $0 | 28,109 (Direct) |
View |
| 2021-05-20 Option Award |
2021-05-24 4:32 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Reinsdorf Judith A Director |
2,635 | $0 | 14,150 (Direct) |
View |
| 2021-05-20 Option Award |
2021-05-24 4:30 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Nader Francois Director |
2,635 | $0 | 13,921 (Direct) |
View |
| 2021-05-20 Option Award |
2021-05-24 4:29 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Mollen John T Director |
2,635 | $0 | 15,336 (Direct) |
View |
| 2021-05-20 Option Award |
2021-05-24 4:27 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Dunsire Deborah Director |
2,495 | $0 | 14,629 (Direct) |
View |
| 2021-05-20 Option Award |
2021-05-24 4:25 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Brennan David R Director |
3,336 | $0 | 20,873 (Direct) |
View |
| 2021-03-29 Tax Withholding |
2021-04-01 07:44 am |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | HANTSON LUDWIG CEO |
2,332 | $154.03 | 349,166 (Direct) |
View |
| 2021-02-28 Option Award |
2021-03-02 6:01 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | HANTSON LUDWIG CEO |
83,725 | $0 | 351,498 (Direct) |
View |
| 2021-02-28 Option Award |
2021-03-02 5:59 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Carino Tanisha EVP & CCAO |
18,033 | $0 | 33,413 (Direct) |
View |
| 2021-03-01 Tax Withholding |
2021-03-02 5:59 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Carino Tanisha EVP & CCAO |
722 | $151.75 | 33,413 (Direct) |
View |
| 2021-02-28 Option Award |
2021-03-02 5:57 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Chiniara Ellen EVP & Chief Legal Officer |
19,321 | $0 | 62,381 (Direct) |
View |
| 2021-02-28 Option Award |
2021-03-02 5:55 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Goff Brian EVP & Chief Commercial Officer |
24,473 | $0 | 91,774 (Direct) |
View |